AMDL, Inc. (ADL) Wrap Up:

AMDL, Inc., specialty pharmaceutical company, through its subsidiary, Jade Pharmaceutical, Inc., engages in the research, development, manufacture, and marketing of diagnostic, pharmaceutical, nutritional supplement, and cosmetic products primarily in China. The company offers DR-70 diagnostic test kit, a tumor-marker biochemical substance, which is used to detect various cancers, including lung (small and non-small cell), stomach, breast, rectal, colon, and liver cancer. The company’s product line also includes a line of non-proprietary cancer tumor markers and non-proprietary test kits, including CEA for colon cancer and PSA for prostate cancer. AMDL also owns a Combination Immunogene Ther...